Resorbability of bone substitute biomaterials by human osteoclasts

Biomaterials

Volumn 25, Issue 18, 2004, Pages 3963-3972

  Schilling, Arndt F ^a   Linhart, Wolfgang ^a   Filke, Sandra ^a   Gebauer, Matthias ^a   Schinke, Thorsten ^a   Rueger, Johannes M ^a   Amling, Michael ^a  

^a University of Medical School Hamburg Eppendorf   (Germany)

Author keywords

Biomimetic material; Bioresorption; Calcium phosphate cement; Cell culture; In vitro test; Osteoclast

Indexed keywords

BIOASSAY; BONE; CALCIUM COMPOUNDS; CELLS; ELECTRON MICROSCOPY; PATIENT TREATMENT; POLYMETHYL METHACRYLATES;

OSTEOCLASTS; RESORBABILITY;

BIOMATERIALS;

BIOMATERIAL; CALCIUM PHOSPHATE; POLY(METHYL METHACRYLATE);

ARTICLE; BIOENGINEERING; BONE DEVELOPMENT; BONE PROSTHESIS; BONE REMODELING; COMPUTER ANALYSIS; DENTIN; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMPLANT; IN VITRO STUDY; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; STANDARD; VALIDATION PROCESS;

ABSORBABLE IMPLANTS; ABSORPTION; BIOCOMPATIBLE MATERIALS; BONE RESORPTION; BONE SUBSTITUTES; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; DENTIN; HUMANS; MATERIALS TESTING; OSTEOBLASTS; OSTEOCLASTS; SURFACE PROPERTIES; TISSUE ENGINEERING;

ANIMALIA;

EID: 1642289893     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2003.10.079     Document Type: Article

References (36)

1. Axhausen G. Die pathologisch-anatomischen Grundlagen der Lehre der freien Knochentransplantation beim Menschen und beim Tier. Med Klin. 2:1908;23-36.
2. Bonatesta G. Die Entwicklung der Knochenplastik im Unterkiefer zwischen 1919 und 1939 in Deutschland. Zur Medizingesch Abh 2000;285:1-73.
3. Burchardt H. The biology of bone graft repair. Clin Orthop 1983;174:28-42.
4. Frost H.M. Bone "mass" and the "mechanostat" a proposal Anat Rec. 219:1987;1-9.
5. Baron R. Molecular mechanisms of bone resorption. An update. Acta Orthop Scand Suppl. 266:1995;66-70.
6. Teitelbaum S.L. Bone resorption by osteoclasts. Science. 289(5484):2000;1504-1508.
7. Parfitt AM.Thephysiologic,clinical significance of bone histomorphometric data. In: Recker RR, editor. Bone histomorphometry: techniques and interpretation. Boca Raton: CRC Press; 1983. p. 143-223.
8. Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., Mochizuki S.et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA. 95:1998;3597-3602.
9. Simonet W.S., Lacey D.L., Dunstan C.R., Kelley M., Chang M.S., Luthy R. et al. Osteoprotegerin. a novel secreted protein involved in the regulation of bone density Cell JID-0413066. 89(2):1997;309-319.
10. Kong Y.Y., Feige U., Sarosi I., Bolon B., Tafuri A., Morony S.et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature. 402(6759):1999;304-309.
11. Nordstrom T., Shrode L.D., Rotstein O.D., Romanek R., Goto T., Heersche J.N.et al. Chronic extracellular acidosis induces plasmalemmal vacuolar type H+ ATPase activity in osteoclasts. J Biol Chem. 272(10):1997;6354-6360.
12. Hattersley G., Chambers T.J. Calcitonin receptors as markers for osteoclastic differentiation. correlation between generation of bone-resorptive cells and cells that express calcitonin receptors in mouse bone marrow cultures Endocrinology. 125(3):1989;1606-1612.
13. Rodan S.B., Rodan G.A. Integrin function in osteoclasts. J Endocrinol. 154(Supp l):1997;S47-S56.
14. Faccio R., Takeshita S., Zallone A., Ross F.P., Teitelbaum S.L. c-Fms and the alphavbeta3 integrin collaborate during osteoclast differentiation. J Clin Invest. 111(5):2003;749-758.
15. Sly W.S., Hewett-Emmett D., Whyte M.P., Yu Y.S., Tashian R.E. Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. Proc Natl Acad Sci USA. 80(9):1983;2752-2756.
16. McMahon C., Will A., Hu P., Shah G.N., Sly W.S., Smith O.P. Bone marrow transplantation corrects osteopetrosis in the carbonic anhydrase II deficiency syndrome. Blood. 97(7):2001;1947-1950.
17. Craelius W. The bionic man. restoring mobility Science. 295(5557):2002;1018-1021.
18. Rueger J.M. Knochenersatzmittel. Heutiger Stand und Ausblick. Orthopade. 27(2):1998;72-79.
19. Dorozhkin S.V., Epple M. Biological and medical significance of calcium phosphates. Angew Chem Int Ed Engl. 41(17):2002;3130-3146.
20. Holden C.M., Bernard G.W. Ultrastructural in vitro characterization of a porous hydroxyapatite/bone cell interface. J Oral Implantol. 16(2):1990;86-95.
21. Wilke A., Schroder G., Orth J., Griss P., Franke R.P. Biokompatibilitätsprüfung von Implantatmaterialien mit humanen Knochenmarkszellkulturen. Biomed Tech (Berl). 38(6):1993;126-129.
22. Orly I., Gregoire M., Menanteau J., Heughebaert M., Kerebel B. Chemical changes in hydroxyapatite biomaterial under in vivo and in vitro biological conditions. Calcif Tissue Int. 45(1):1989;20-26.
23. Linhart W., Peters F., Lehmann W., Schwarz K., Schilling A.F., Amling M.et al. Biologically and chemically optimized composites of carbonated apatite and polyglycolide as bone substitution materials. J Biomed Mater Res. 54(2):2001;162-171.
24. Langstaff S., Sayer M., Smith T.J., Pugh S.M. Resorbable bioceramics based on stabilized calcium phosphates. Part II. evaluation of biological response Biomaterials. 22(2):2001;135-150.
25. Taylor J.C., Cuff S.E., Leger J.P., Morra A., Anderson G.I. In vitro osteoclast resorption of bone substitute biomaterials used for implant site augmentation. a pilot study Int J Oral Maxillofac Implants. 17(3):2002;321-330.
26. Zambonin-Zallone A., Teti A., Primavera M.V. Isolated osteoclasts in primary culture. first observations on structure and survival in culture media Anat Embryol Berl. 165:1982;405-413.
27. Jones SJ, Boyde A, Ali NN, Maconnachie E. Variation in the sizes of resorption lacunae made in vitro. Scan Electron Microsc 1986;Part 4:1571-80.
28. Walker DG. Bone resorption restored in osteopetrotic mice by transplants of normal bone marrow, spleen cells. 1975. Clin Orthop 1993;294:4-6.
29. Udagawa N., Takahashi N., Akatsu T., Tanaka H., Sasaki T., Nishihara T. et al. Origin of osteoclasts. mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells Proc Natl Acad Sci USA. 87:1990;7260-7264.
30. Simonet W.S., Lacey D.L., Dunstan C.R., Kelley M., Chang M.S., Luthy R. et al. Osteoprotegerin. a novel secreted protein involved in the regulation of bone density Cell. 89(2):1997;309-319.
31. Bucay N., Sarosi I., Dunstan C.R., Morony S., Tarpley J., Capparelli C. et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 12:1998;395-400.
32. Hentunen T.A., Jackson S.H., Chung H., Reddy S.V., Lorenzo J., Choi S.J.et al. Characterization of immortalized osteoclast precursors developed from mice transgenic for both bcl-X(L) and simian virus 40 large T antigen. Endocrinology. 140(7):1999;2954-2961.
33. Monchau F., Lefevre A., Descamps M., Belquin-myrdycz A., Laffargue P., Hildebrand H.F. In vitro studies of human and rat osteoclast activity on hydroxyapatite, beta-tricalcium phosphate, calcium carbonate. Biomol Eng. 19(2-6):2002;143-152.
34. Shibutani T., Heersche J.N. Effect of medium pH on osteoclast activity and osteoclast formation in cultures of dispersed rabbit osteoclasts. J Bone Miner Res. 8(3):1993;331-336.
35. Baron R., Ravesloot J.H., Neff L., Chakraborty M., Chatterjee D., Lomri A.et al. Cellular and molecular biology of the osteoclast. Noda M. Cellular and molecular biology of bone. 1993;445-495 Academic Press, Inc. San Diego.
36. Xia Z.D., Zhu T.B., Du J.Y., Zheng Q.X., Wang L., Li S.P.et al. Macrophages in degradation of collagen/hydroxylapatite(CHA), beta-tricalcium phosphate ceramics (TCP) artificial bone graft. An in vivo study. Chin Med J. 107(11):1994;845-849. (in English).